Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Herman Weiss
Differences in Reporting Pearl Indices in the United States and Europe: Focus on a 91-Day Extended-Regimen Combined Oral Contraceptive With Low-Dose Ethinyl Estradiol Supplementation
European Journal of Contraception and Reproductive Health Care
Medicine
Gynecology
Reproductive Medicine
Pharmacology
Obstetrics
Related publications
Efficacy in Suppressing Ovulation and Safety of a Low Dose Oral Contraceptive in a Continuous Regimen (84+7) With Continuous Ethinyl Estradiol Instead of a Hormone-Free Interval: An Evaluation of Ovulation Suppression and Ovarian Activity
World Journal of Gynecology & Womens Health
Unscheduled Bleeding in Combined Oral Contraceptive Users: Focus on Extended-Cycle and Continuous-Use Regimens
Journal of Family Planning and Reproductive Health Care
A Combined Oral Contraceptive Containing 30 MCG Ethinyl Estradiol and 3.0 Mg Drospirenone Does Not Impair Endothelium-Dependent Vasodilation
Contraception
Gynecology
Reproductive Medicine
Obstetrics
Drospirenone/Ethinyl Estradiol 3 Mg/20 &Micro;g (24/4 Day Regimen): Hormonal Contraceptive Choices &Ndash; Use of a Fourth-Generation Progestin
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Yasminelle®: A New Low-Dose Combined Oral Contraceptive Containing Drospirenone
Women's Health
Medicine
The Evra (Ethinyl Estradiol/Norelgestromin) Contraceptive Patch: Estrogen Exposure Concerns
CMAJ
Medicine
Endometrial Safety With a 1-Year Segesterone Acetate/Ethinyl Estradiol Contraceptive Vaginal System [5M]
Obstetrics and Gynecology
Gynecology
Obstetrics
An Overview of the Development of Combined Oral Contraceptives Containing Estradiol: Focus on Estradiol Valerate/Dienogest
Gynecological Endocrinology
Gynecology
Endocrinology
Metabolism
Obstetrics
Diabetes
Efficacy and Tolerability of a Monophasic Combined Oral Contraceptive Containing Nomegestrol Acetate and 17β-Oestradiol in a 24/4 Regimen, in Comparison to an Oral Contraceptive Containing Ethinylestradiol and Drospirenone in a 21/7 Regimen
European Journal of Contraception and Reproductive Health Care
Medicine
Gynecology
Reproductive Medicine
Pharmacology
Obstetrics
